Chinese drug stocks surge as flu overtakes… “It’s a short-term trade and the momentum may not last too long,” said Dai Ming, a fund manager at Huichen Asset…
Why Biden’s surprise Ukraine visit adds to… China’s close ties with Russia have already increased the geopolitical risks Chinese stocks face. But a surprise…
Upbeat January sentiment spurs rebound in China… Emerging market securities attracted around US$65.7 billion in January, the highest total since the same month in…
China set for ‘steady, continuous’ foreign… Foreign investors bought a net US$12.6 billion of stocks and bonds in the first half of January, the State…
Morgan Stanley lifts MSCI China target on robust… The alignment of economic, regulatory and Covid policies for the first time in four years is likely to result in…
Hong Kong stocks tumble on Covid threat as… Stocks take a bad turn in the final days of 2022 amid concerns about potential new Covid variants, which has…
Traders bet on cold medicine, antigen test… They are betting demand for these products will spike as China allows people to isolate at home and drops…
Cao Cao Mobility said to pick three banks to… Chinese ride-hailing firm Cao Cao Mobility will add to the IPO pipeline in Hong Kong as analysts predict a rebound…
Time to be China stock bulls as zero-Covid ‘has… Investors look at computer screens in front of an electronic board showing stock information at a brokerage…
Why investors are treading carefully on China… While Citic Securities, CICC and Haitong Securities expect the fine-tuning of Covid restrictions to provide…